Further study showed that miR‐150 and SRF are involved in the profibrogenic effect of HOTTIP, which implies that targeting the HOTTIP‐miR‐150‐SRF axis may signify a new therapeutic application in liver fibrosis. The gene discussed is HOTTIP; the disease is Hepatic fibrosis.